Drug-binding and other physicochemical properties of a large tryptic and a large peptic fragment of human serum albumin.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Biochimica et Biophysica Acta

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0167-4838(88)90007-6PMID 3124878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Procedure for the isolation of a large peptic fragment of human serum albumin.

  1988cited by this paper
• Serum albumin.

  1985cited by this paper
• Evidence for the fatty acid-induced heterogeneity of the N and B conformations of human serum albumin.

  1985cited by this paper
• Structural requirements for drug binding to site II on human serum albumin.

  1983cited by this paper
• A Simple Method for Isolating Laboratory Scale Quantities of Human Serum Albumin

  1982cited by this paper
• A comparative study of some physico-chemical properties of human serum albumin samples from different sources--II. The characteristics of the N-B transition and the binding behaviour with regard to warfarin and diazepam.

  1982cited by this paper
• Nucleotide sequence and the encoded amino acids of human serum albumin mRNA.

  1982cited by this paper
• Molecular aspects of ligand binding to serum albumin.

  1981cited by this paper
• The effect of chloride on the binding of warfarin to albumin as a function of pH.

  1981cited by this paper
• Human serum albumin as an allosteric two-state protein. Evidence from effects of calcium and warfarin on proton binding behaviour.

  1981cited by this paper
• The role of albumin conformation in the binding of diazepam to human serum albumin.

  1980cited by this paper
• Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.

  1979cited by this paper
• A highly reactive tyrosine residue as part of the indole and benzodiazepine binding site of human serum albumin.

  1979cited by this paper
• The reactive tyrosine residue of human serum albumin: characterization of its reaction with diisopropylfluorophosphate.

  1979cited by this paper
• Human serum albumin as a 'silent receptor' for drugs and endogenous substances.

  1979cited by this paper
• Steric accessibility of tyrosine residues in human serum albumin

  1979cited by this paper
• The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin.

  1979cited by this paper
• The Modification of the Lone Tryptophan Residue in Human Serum Albumin by 2-Hydroxy-5-nitrobenzyl Bromide

  1978cited by this paper
• Physical and binding properties of large fragments of human serum albumin.

  1977cited by this paper
• Isolation and identification of a trypsin-resistant fragment of human serum albumin with bilirubin- and drug-binding properties.

  1977cited by this paper
• Concentration-dependent effects of fatty acids on warfarin binding to albumin.

  1977cited by this paper
• Correlation between arginyl residue modification and benzodiazepine binding to human serum albumin.

  1977cited by this paper
• Independent binding of ligands to human serum albumin.

  1977cited by this paper
• Further characterization of specific drug binding sites on human serum albumin.

  1976cited by this paper
• Fragments of bovine serum albumin produced by limited proteolysis. Isolation and characterization of tryptic fragments.

  1975cited by this paper
• Positions in human serum albumin which involve the indole binding site. Sequence of 107-residue fragment.

  1975cited by this paper
• Complete amino acid sequence of human serum albumin

  1975cited by this paper
• The neutral transition and the environment of the sulfhydryl side chain of bovine plasma albumin.

  1974cited by this paper
• Synthesis of carbon‐14 labeled 1,4‐benzodiazepnies. II.(1) diazepam‐14C, demethyldiazepam‐14C, and ketazolam‐14C

  1974cited by this paper
• Studies on the tryptophan and drug-binding properties of human serum albumin fragments by affinity chromatography and circular dichroism measurements.

  1973cited by this paper
• OVERVIEW OF DRUG‐PROTEIN BINDING

  1973cited by this paper
• Reversible denaturation of human serum albumin by pH, temperature, and guanidine hydrochloride followed by optical rotation.

  1973cited by this paper
• Amino acid sequences of the amino and the carboxyl terminal cyanogen bromide peptides of bovine plasma albumin.

  1972cited by this paper
• Determination of protein: a modification of the Lowry method that gives a linear photometric response.

  1972cited by this paper
• pK change of imidazole groups in bovine serum albumin due to the conformational change at neutral pH.

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Structural studies and organic ligand-binding properties of bovine plasma albumin.

  1970cited by this paper
• Removal of fatty acids from serum albumin by charcoal treatment.

  1967cited by this paper
• Determination of sulfhydryl groups with 2,2'- or 4,4'-dithiodipyridine.

  1967cited by this paper
• On the nature of allosteric transitions: implications of non-exclusive ligand binding.

  1966cited by this paper
• Potential effect of the plasma on drug distribution.

  1965cited by this paper
• Potential Effect of the Plasma Proteins on Drug Distribution

  1965cited by this paper
• ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.

  1965cited by this paper
• A structural transformation in bovine and human plasma albumins in alkaline solution as revealed by rotatory dispersion studies.

  1963cited by this paper

• Chiral separation of propranolol by electrokinetic chromatography using nanodiamonds and human serum albumin as a pseudo-stationary phase in river water.

  2024cites this paper
• Unraveling the versatility of human serum albumin – A comprehensive review of its biological significance and therapeutic potential

  2023cites this paper
• Shedding light on the bimolecular interactions of Cafaminol and human serum albumin: spectroscopic characterization and in-silico investigation

  2021cites this paper
• Studies on the Interaction of Cefepime Hydrochloride with Bovine Serum Albumin by Fluorescence, Synchronous Fluorescence, Three-Dimensional Fluorescence and Circular Dichroism

  2017cites this paper
• Thermo-reversibility, ergodicity and surface charge–temperature dependent phase diagram of anionic, cationic and neutral co-gels of gelatin–BSA complexes

  2016cites this paper
• Understanding the interaction between human serum albumin and anti-bacterial/ anti-cancer compounds.

  2015cites this paper
• Interactive Association of Drugs Binding to Human Serum Albumin

  2014cites this paper
• Influences of pH, urea and metal ions on the interaction of sinomenine with Lysozyme by steady state fluorescence spectroscopy.

  2014cites this paper
• Influences of urea and pH on the interaction of cinchonidine with bovine serum albumin by steady state fluorescence spectroscopy.

  2013cites this paper
• Albumin-drug interaction and its clinical implication.

  2013cites this paper
• Stereoselective binding of chiral drugs to plasma proteins

  2013cites this paper
• Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains

  2012cites this paper
• Investigation on the pH-dependent binding of vitamin B12 and lysozyme by fluorescence and absorbance

  2012cites this paper
• Effect of pH on the interaction of vitamin B12 with bovine serum albumin by spectroscopic approaches.

  2011cites this paper
• Investigation on the pH-dependent binding of benzocaine and lysozyme by fluorescence and absorbance.

  2011cites this paper
• Effect of pH on the interaction of baicalein with lysozyme by spectroscopic approaches.

  2011cites this paper
• Analysis of local polarity change around Cys34 in bovine serum albumin during N-->B transition by a polarity-sensitive fluorescence probe.

  2009cites this paper
• Characterization of the binding of nevadensin to bovine serum albumin by optical spectroscopic technique

  2008cites this paper
• Conformation selectivity in the binding of diazepam and analogues to alpha1-acid glycoprotein.

  2007cites this paper
• Lungfish albumin is more similar to tetrapod than to teleost albumins: purification and characterisation of albumin from the Australian lungfish, Neoceratodus forsteri.

  2007cites this paper
• In vitro study on the binding of neutral red to bovine serum albumin by molecular spectroscopy

  2006cites this paper
• Abstracts of Dutch doctoral theses

  2005cites this paper
• Interaction between hesperetin and human serum albumin revealed by spectroscopic methods.

  2005cites this paper
• Guanidine hydrochloride denaturation of human serum albumin originates by local unfolding of some stable loops in domain III.

  2005cites this paper
• Alkali-induced conformational transition in different domains of bovine serum albumin.

  2004cites this paper
• Intermediate formation at lower urea concentration in 'B' isomer of human serum albumin: a case study using domain specific ligands.

  2004cites this paper
• Studies of human serum albumin-ligand interactions using site-directed mutants and recombinant fragments of the protein

  2004cites this paper
• Using serum albumin to infer vertebrate phylogenies.

  2003cites this paper
• Conformational Transitions of the Three Recombinant Domains of Human Serum Albumin Depending on pH*

  2000cites this paper
• Protein–Drug Interactions

  2000cites this paper
• The Three Recombinant Domains of Human Serum Albumin

  1999cites this paper
• Chirality and Spectroscopic Changes Induced by the Recognition of Ethyl 5‐Amino‐2‐methyl‐1,2‐dihydro‐3‐phenylpyrido[3,4‐b]pyrazin‐7‐yl Carbamate Analogs by Tubulin

  1999cites this paper
• Expression of a Human Serum Albumin Fragment (Consisting of Subdomains IA, IB, and IIA) and a Study of Its Properties

  1999cites this paper
• Albumin Church Bay: 560 Lys-->Glu a new mutation detected by electrospray ionisation mass spectrometry.

  1998cites this paper
• Interaction of bromocresol green with different serum albumins studied by fluorescence quenching

  1997cites this paper
• pH-Dependent regulation of leukocyte 5-lipoxygenase activity in inflammatory exudates by albumin

  1997cites this paper
• Solvatochromic analysis of di-n-butyl ether/water partition coefficients as compared to other solvent systems

  1997cites this paper
• Intracellular localisation of suramin, an anticancer drug, in human colon adenocarcinoma cells: a study by quantitative autoradiography.

  1996cites this paper
• The physicochemical and biopharmaceutical properties of fragmented keratin as a new drug carrier.

  1996cites this paper
• Structure and ligand-binding modes of human serum albumin studied by UV resonance raman spectroscopy

  1995cites this paper
• Chapter 6 Analysis of protein structure by circular dichroism spectroscopy

  1994cites this paper
• Drug binding properties of glycosylated bovine serum albumin as measured by circular dichroism.

  1994cites this paper
• Multiple effects of haemin binding on protease susceptibility of bovine serum albumin and a novel isolation procedure for its large fragment.

  1994cites this paper
• Steroid binding to human serum albumin and fragments thereof. Role of protein conformation and fatty acid content.

  1993cites this paper
• Study of interaction of carprofen and its enantiomers with human serum albumin--I. Mechanism of binding studied by dialysis and spectroscopic methods.

  1993cites this paper
• Effect of albumin on adenylate cyclase receptor-related signal transduction of human peripheral blood mononuclear cells.

  1992cites this paper
• High-affinity binding of warfarin, salicylate and diazepam to natural mutants of human serum albumin modified in the C-terminal end.

  1992cites this paper
• Albumin Rugby Park: a truncated albumin variant caused by a G-->C splice-site mutation in intron 13.

  1992cites this paper
• Octanoate binding to the indole- and benzodiazepine-binding region of human serum albumin.

  1991cites this paper
• Structural characterization of a glycoprotein variant of human serum albumin: albumin Casebrook (494 Asp----Asn).

  1991cites this paper
• The stimulatory effect of albumin on luteinizing hormone-stimulated Leydig cell steroid production depends on its fatty acid content and correlates with conformational changes.

  1991influential citation
• Stereoselectivity of the binding of drugs by blood plasma proteins (review)

  1990cites this paper
• Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site.

  1990cites this paper
• Thermodynamics of the interaction of benzodiazepines with human serum albumin

  1990cites this paper
• Conformational changes in human serum albumin induced by ligand binding.

  1990cites this paper
• Location and characterization of the suramin binding sites of human serum albumin.

  1990cites this paper
• Novel human proalbumin variant with intact dibasic sequence facilitates identification of its converting enzyme.

  1989cites this paper
• The molecular mechanism of the neutral-to-base transition of human serum albumin. Acid/base titration and proton nuclear magnetic resonance studies on a large peptic and a large tryptic fragment of albumin.

  1989cites this paper
• Mechanism by which warfarin binds to human serum albumin. Stopped-flow kinetic experiments with two large fragments of albumin.

  1989cites this paper
• Three-dimensional structure of human serum albumin.

  1989cites this paper
• Location and characterization of the warfarin binding site of human serum albumin. A comparative study of two large fragments.

  1988cites this paper